Additional Supporting Information may be found in the online version of this article.

HEP_24133_sm_suppinfofig1.tif3854KSupporting Information Figure 1
HEP_24133_sm_suppinfofig2.tif1687KSupporting Information Figure 2
HEP_24133_sm_suppinfofig3.tif2932KSupporting Information Figure 3
HEP_24133_sm_suppinfofig4.tif3847KSupporting Information Figure 4
HEP_24133_sm_suppinfofig5.tif220KSupporting Information Figure 5
HEP_24133_sm_suppinfofig6.tif2967KSupporting Information Figure 6
HEP_24133_sm_suppinfotable1.doc117KSupporting Table 1: Known tumor suppressor genes in the three most frequently deleted regions of chromosome 4.
HEP_24133_sm_suppinfotable2.doc22KSupporting Table 2 Percentage of tumors with specific mutations observed in all tumors with β-catenin mutations.
HEP_24133_sm_suppinfotable3.doc20KSupporting Table 3 H-Ras sequencing results
HEP_24133_sm_suppinfotable4.doc25KSupporting Table 4 Results of immunohistochemical β-catenin- and Ki67-staining in early and late stage liver tumors induced by DEN and PB.
HEP_24133_sm_suppinfo.doc47KSupporting Information

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.